CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary intervention-Reference-Cited by-同舟云学术

CYP2C19 genotyping combined with on-clopidogrel platelet reactivity in predicting major adverse cardiovascular events in Chinese patients with percutaneous coronary intervention

Published:2016-11 Issue: Volume:147 Page:108-114
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Tang Xiao-Fang,Han Ya-Ling,Zhang Jia-Hui,Wang Jing,Yao Yi,He Chen,Xu Bo,Gao Zhan,Qiao Shu-Bin,Chen Jue,Wu Yuan,Chen Ji-Lin,Gao Run-Lin,Yang Yue-Jin,Yuan Jin-Qing

Funder

National Research Key Project of The Twelfth Five-Year Plan of Republic of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Hematology

Reference32 articles.

1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

2. 2011 accf/aha/scai guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions;Levine;Catheter. Cardiovasc. Interv.,2013

3. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives;Angiolillo;J. Am. Coll. Cardiol.,2007

4. Determinants to optimize response to clopidogrel in acute coronary syndrome;Giusti;Pharmgenomics Pers. Med.,2010

5. Reduced-function cyp2c19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for pci: a meta-analysis;Mega;JAMA,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical Biosensor for Detection of the CYP2C19*2 Allele Based on Exonuclease Ⅲ;Micromachines;2023-02-25

2. The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-02

3. Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study;BMC Cardiovascular Disorders;2021-08-12

4. The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention;European Journal of Clinical Pharmacology;2021-06-23

5. A genetic polymorphism in P2RY1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy;Scientific Reports;2021-06-15